Sign in
CompletedNo phase

One-shot Ovarian Stimulation Protocol (One-shot)

Key facts

Who runs it
Fundación Santiago Dexeus Font
Where
Spain3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
20 people enrolled
Started
31 Oct 2024
Ended
11 Nov 2025
Type of study
Interventional
Treatments tested
  • Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1
  • Clomiphene Citrate (CC) 100 mg/day from D1
  • Monitoring cycle
Record updated
8 September 2026

Who can take part

Age
18 years to 40 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Age <= 40
  • AMH (Anti-Mullerian Hormone) 1.2-3.5 ng/ml or AFC 7-20
  • No family history of hereditary or chromosomal diseases
  • Body mass index (BMI) 18 to 30 kg/m2

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).

The group in the trial

  • Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1Treatment being tested

    Treatment: Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1, Clomiphene Citrate (CC) 100 mg/day from D1, and Monitoring cycle

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
One-Shot Ovarian Stimulation Protocol: A Pilot Study Investigating the Endocrine Profile
Record updated
8 September 2026